BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4587069)

  • 1. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 2. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-sex differences in response to antidepressant drugs.
    Raskin A
    J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs and group psychotherapy in neurotic depression.
    Covi L; Lipman RS; Derogatis LR; Smith JE; Pattison JH
    Am J Psychiatry; 1974 Feb; 131(2):191-8. PubMed ID: 4587808
    [No Abstract]   [Full Text] [Related]  

  • 5. The NIMH collaborative depression studies--a progress report.
    Raskin A
    Psychopharmacol Bull; 1972 Jul; 8(3):55-9. PubMed ID: 4559524
    [No Abstract]   [Full Text] [Related]  

  • 6. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive classification and prediction of response to phenelzine.
    Paykel ES; Parker RR; Penrose RJ; Rassaby ER
    Br J Psychiatry; 1979 Jun; 134():572-81. PubMed ID: 476367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium prophylaxis in recurrent affective illness.
    Prien RF; Klett CJ; Caffey EM
    Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
    [No Abstract]   [Full Text] [Related]  

  • 11. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects.
    Raskin A; Crook TH
    J Psychiatr Res; 1976; 13(1):31-41. PubMed ID: 966189
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien.
    Covington JS
    South Med J; 1975 Jun; 68(6):719-24. PubMed ID: 1094544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety.
    Tyrer P; Candy J; Kelly D
    Psychopharmacologia; 1973 Sep; 32(3):237-54. PubMed ID: 4586902
    [No Abstract]   [Full Text] [Related]  

  • 16. A model for drug use with depressed patients.
    Raskin A; Boothe H; Schulterbrandt JG; Reatig N; Odle D
    J Nerv Ment Dis; 1973 Feb; 156(2):130-42. PubMed ID: 4570135
    [No Abstract]   [Full Text] [Related]  

  • 17. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders.
    Prange AJ; Wilson IC; Lynn CW; Alltop LB; Stikeleather RA
    Arch Gen Psychiatry; 1974 Jan; 30(1):56-62. PubMed ID: 4587067
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
    Cooper AJ; Magnus RV; Rose M; Phanjoo A; Lancaster NP; Pollard P; Knowlson P
    Br J Psychiatry; 1973 Oct; 123(575):475-6. PubMed ID: 4584032
    [No Abstract]   [Full Text] [Related]  

  • 19. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A; Crook TH
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.